The Directors Team at Syndax Pharmaceuticals is responsible for setting strategic direction, overseeing clinical development programs, guiding regulatory affairs, and ensuring compliance with good manufacturing practices (GMP) quality standards for commercial operations. Their collective efforts aim to advance the company's pipeline of innovative cancer therapies.